Kevin B. Kim
- Molecular Biology top 1%
- Oncology top 0.2%
- Pulmonary and Respiratory Medicine top 1%
- Immunology top 2%
- Cancer Research top 2%
- Co-authors
- Antoni RibasJeffrey A. SosmanGrant A. McArthurK. B. NolopRichard J. LeeKeith T. FlahertyIgor PuzanovPaul B. Chapman
- Topics
- Melanoma and MAPK Pathways (66 papers)Cutaneous Melanoma Detection and Management (50 papers)CAR-T cell therapy research (26 papers)
- Partner nations
- United StatesAustraliaSwitzerland
In The Last Decade
Kevin B. Kim
111 papers receiving 8.1k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Molecular Biology 5.4k
- Oncology 5.1k
- Pulmonary and Respiratory Medicine 1.5k
- Immunology 1.0k
- Cancer Research 970
Countries citing papers authored by Kevin B. Kim
This map shows the geographic impact of Kevin B. Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin B. Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin B. Kim more than expected).
Fields of papers citing papers by Kevin B. Kim
This network shows the impact of papers produced by Kevin B. Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin B. Kim. The network helps show where Kevin B. Kim may publish in the future.
Co-authorship network of co-authors of Kevin B. Kim
This figure shows the co-authorship network connecting the top 25 collaborators of Kevin B. Kim. A scholar is included among the top collaborators of Kevin B. Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin B. Kim. Kevin B. Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 5 | |
| 4 | 50 | |
| 5 | 0 | |
| 6 | 10 | |
| 7 | 12 | |
| 8 | 8 | |
| 9 | 37 | |
| 10 | 14 | |
| 11 | 6 | |
| 12 | 34 | |
| 13 | 57 | |
| 14 | 338 | |
| 15 | 39 | |
| 16 | 356 | |
| 17 | 100 | |
| 18 | 148 | |
| 19 | 53 | |
| 20 | 141 |
About Kevin B. Kim
Kevin B. Kim is a scholar working on Oncology, Molecular Biology and Hematology, having authored 116 papers that have together received 8.2k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (66 papers), Cutaneous Melanoma Detection and Management (50 papers) and CAR-T cell therapy research (26 papers). The work is most often cited by research in Oncology (5.1k citations), Molecular Biology (5.4k citations) and Cancer Research (970 citations). Kevin B. Kim has collaborated with scholars based in United States, Australia and Switzerland. Frequent co-authors include Antoni Ribas, Jeffrey A. Sosman, Grant A. McArthur, K. B. Nolop, Richard J. Lee, Keith T. Flaherty, Igor Puzanov, Paul B. Chapman, Joseph F. Grippo and Peter J. O’Dwyer. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.